Paragon Capital Management (Colorado)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$325K Sell
835
-2
-0.2% -$798 0.06% 102
2026
Q2
$324K Buy
+837
New +$310K 0.06% 105
2022
Q2
– Sell
-532
Closed -$261K – 178
2022
Q1
$261K Buy
532
+17
+3% +$7.77K 0.05% 111
2021
Q4
$239K Buy
+515
New +$217K 0.04% 127
2018
Q1
– Sell
-1,550
Closed -$349K – 224
2017
Q4
$349K Hold
1,550
– – 0.14% 69
2017
Q3
$294K Buy
+1,550
New +$295K 0.11% 108
2017
Q2
– Sell
-1,391
Closed -$230K – 186
2017
Q1
$230K Buy
+1,391
New +$221K 0.1% 104

Other funds holding ELV

Paragon Capital Management (Colorado)'s ELV Position: Q3 2026 in Review

Paragon Capital Management (Colorado) reduced its Elevance Health (ELV) stake by 0.24% in Q3 2026, selling an estimated $798 and leaving 835 shares worth $325K. The position accounts for 0.06% of the portfolio, ranked #102.

Paragon Capital Management (Colorado) first reported a position in ELV in Q1 2017 and has held it in 7 quarters since. The position peaked at $349K in Q4 2017. 204 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Paragon Capital Management (Colorado) held 835 shares of Elevance Health worth $325K as of Q3 2026.
  • Paragon Capital Management (Colorado) sold 2 Elevance Health shares in Q3 2026, an estimated $798.
  • Elevance Health made up 0.06% of Paragon Capital Management (Colorado)'s portfolio in Q3 2026, its #102 holding.
  • Paragon Capital Management (Colorado) first reported a position in Elevance Health in Q1 2017 and has held it in 7 quarters since.
  • Paragon Capital Management (Colorado)'s Elevance Health position peaked at $349K in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q3 2026, filed 9 Oct 2026.